Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Winn

Showing results (221-230 of 414) with videos related to

Pageof 42
Sort By:
Journal of Medicinal Chemistry|April 1, 1976
Drugs derived from cannabinoids. 4. Effect of alkyl substitution in sulfur and carbocyclic analogsR K Razdan, G R Handrick, H C Dalzell, et al.
Environmental Toxicology and Chemistry|July 31, 2025
First assessment of the ecotoxicological effects of the tire antioxidant 6PPD on early life stages of the popular sport fish species, the largemouth bass (Micropterus nigricans)Katryna J Seabrook, Louise M Winn, Markus Brinkmann, et al.
Cancer Research|June 1, 1991
Mouthwash use and oral conditions in the risk of oral and pharyngeal cancerD M Winn, W J Blot, J K McLaughlin, et al.
Cancer Causes & Control : CCC|September 8, 2001
Mouthwash in the etiology of oral cancer in Puerto RicoD M Winn, S R Diehl, L M Brown, et al.
Journal of Medicinal Chemistry|April 1, 1976
Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chainsM Winn, D Arendsen, P Dodge, et al.
Journal of Medicinal Chemistry|September 10, 1999
Design, synthesis, and activity of a series of pyrrolidine-3-carboxylic acid-based, highly specific, orally active ET(B) antagonists containing a diphenylmethylamine acetamide side chainG Liu, N S Kozmina, M Winn, et al.
Journal of Receptor Research|May 1, 1994
Receptor interactions of Abbott-81988, a highly potent, non-peptide angiotensin-II antagonist selective for type-1 receptorsA A Hancock, S A Buckner, J Y Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 12, 2013
Epigenetic research in cancer epidemiology: trends, opportunities, and challengesMukesh Verma, Scott Rogers, Rao L Divi, et al.
Journal of Medicinal Chemistry|September 3, 1993
2-(Alkylamino)nicotinic acid and analogs. Potent angiotensin II antagonistsM Winn, B De, T M Zydowsky, et al.
Life Sciences|January 1, 1993
Pharmacological characterization of Abbott-81282, a novel, non-peptide angiotensin-II antagonist selective for type-1 receptorsA A Hancock, S A Buckner, J Y Lee, et al.
Pageof 42

Showing results (221-230 of 414) with videos related to

Sort By:
Pageof 42
Journal of Medicinal Chemistry|April 1, 1976
Drugs derived from cannabinoids. 4. Effect of alkyl substitution in sulfur and carbocyclic analogsR K Razdan, G R Handrick, H C Dalzell, et al.
Environmental Toxicology and Chemistry|July 31, 2025
First assessment of the ecotoxicological effects of the tire antioxidant 6PPD on early life stages of the popular sport fish species, the largemouth bass (Micropterus nigricans)Katryna J Seabrook, Louise M Winn, Markus Brinkmann, et al.
Cancer Research|June 1, 1991
Mouthwash use and oral conditions in the risk of oral and pharyngeal cancerD M Winn, W J Blot, J K McLaughlin, et al.
Cancer Causes & Control : CCC|September 8, 2001
Mouthwash in the etiology of oral cancer in Puerto RicoD M Winn, S R Diehl, L M Brown, et al.
Journal of Medicinal Chemistry|April 1, 1976
Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chainsM Winn, D Arendsen, P Dodge, et al.
Journal of Medicinal Chemistry|September 10, 1999
Design, synthesis, and activity of a series of pyrrolidine-3-carboxylic acid-based, highly specific, orally active ET(B) antagonists containing a diphenylmethylamine acetamide side chainG Liu, N S Kozmina, M Winn, et al.
Journal of Receptor Research|May 1, 1994
Receptor interactions of Abbott-81988, a highly potent, non-peptide angiotensin-II antagonist selective for type-1 receptorsA A Hancock, S A Buckner, J Y Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 12, 2013
Epigenetic research in cancer epidemiology: trends, opportunities, and challengesMukesh Verma, Scott Rogers, Rao L Divi, et al.
Journal of Medicinal Chemistry|September 3, 1993
2-(Alkylamino)nicotinic acid and analogs. Potent angiotensin II antagonistsM Winn, B De, T M Zydowsky, et al.
Life Sciences|January 1, 1993
Pharmacological characterization of Abbott-81282, a novel, non-peptide angiotensin-II antagonist selective for type-1 receptorsA A Hancock, S A Buckner, J Y Lee, et al.
Pageof 42